ETF Managers Group’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$1.09M	Buy	130,676 +84,198	+181%	+$811K	0.04%	206
2022 Q4	$534K	Sell	46,478 -8,393	-15%	-$105K	0.03%	347
2022 Q3	$691K	Sell	54,871 -3,774	-6%	-$48.6K	0.02%	271
2022 Q2	$634K	Buy	58,645 +2,631	+5%	+$27.1K	0.02%	319
2022 Q1	$921K	Buy	56,014 +1,631	+3%	+$26.2K	0.02%	298
2021 Q4	$750K	Sell	54,383 -10,929	-17%	-$145K	0.01%	397
2021 Q3	$939K	Buy	65,312 +12,900	+25%	+$203K	0.02%	281
2021 Q2	$812K	Sell	52,412 -1,860	-3%	-$25.3K	0.01%	291
2021 Q1	$542K	Sell	54,272 -31,608	-37%	-$326K	0.01%	413
2020 Q4	$644K	Sell	85,880 -13,069	-13%	-$67.4K	0.01%	298
2020 Q3	$379K	Buy	98,949 +50,274	+103%	+$215K	0.01%	371
2020 Q2	$242K	Buy	+48,675	New	+$194K	0.01%	524